Literature DB >> 17333007

Alterations in presenilin 1 processing by amyloid-beta peptide in the rat retina.

Helena R Watts1, Valerie Vince, Desmond T Walsh, Laura G Bresciani, Stephen M Gentleman, Ling-Sun Jen, Peter J B Anderson.   

Abstract

Accumulating evidence indicates that mutations in the presenilin 1 (PS1) gene are responsible for most cases of familial Alzheimer's disease (AD). Although its biological functions are not yet fully understood, it appears that PS1 plays a role in the processing and trafficking of the amyloid precursor protein (APP). However, little is known about factors that are involved in regulating the metabolism of PS1 especially in relation to AD pathology. In this study, we have examined the effect of optic nerve crush, intravitreal injection of the inflammatory agent lipopolysaccharide (LPS) or injection of amyloid beta(1-42) (A beta(1-42)) on the expression and processing of PS1 in the rat retina. We found that 48 h after injection of A beta(1-42) there was a dramatic alteration in the banding pattern of PS1 on Western blots, as indicated by marked changes in the levels of expression of some of its C- and N-terminal fragments in retinal homogenates. These results suggest an A beta(1-42)-induced potentiation of a non-specific stress-related but inflammation-independent alteration of processing of PS1 in this in vivo model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17333007     DOI: 10.1007/s00221-007-0904-5

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   2.064


  47 in total

1.  Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death.

Authors:  B J Passer; L Pellegrini; P Vito; J K Ganjei; L D'Adamio
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

2.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 3.  Molecular genetics of Alzheimer's disease.

Authors:  P H St George-Hyslop
Journal:  Biol Psychiatry       Date:  2000-02-01       Impact factor: 13.382

4.  Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain.

Authors:  S Pablo Sardi; Joshua Murtie; Samir Koirala; Brooke A Patten; Gabriel Corfas
Journal:  Cell       Date:  2006-10-06       Impact factor: 41.582

5.  Membrane topology of the C. elegans SEL-12 presenilin.

Authors:  X Li; I Greenwald
Journal:  Neuron       Date:  1996-11       Impact factor: 17.173

6.  Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia.

Authors:  H Tanimukai; K Imaizumi; T Kudo; T Katayama; M Tsuda; T Takagi; M Tohyama; M Takeda
Journal:  Brain Res Mol Brain Res       Date:  1998-03-01

7.  Sensitization of differentiated PC12 cells to apoptosis by presenilin-2 is mediated by p38.

Authors:  J Sun; M Li; J Han; J Gu
Journal:  Biochem Biophys Res Commun       Date:  2001-09-21       Impact factor: 3.575

8.  Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein.

Authors:  Tadanori Hamano; Tatsuro Mutoh; Takeshi Tabira; Wataru Araki; Masaru Kuriyama; Takateru Mihara; Shigeaki Yano; Hiroko Yamamoto
Journal:  Brain Res Mol Brain Res       Date:  2005-03-19

9.  Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals.

Authors:  Q Guo; B L Sopher; K Furukawa; D G Pham; N Robinson; G M Martin; M P Mattson
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

10.  Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression.

Authors:  J P Roperch; V Alvaro; S Prieur; M Tuynder; M Nemani; F Lethrosne; L Piouffre; M C Gendron; D Israeli; J Dausset; M Oren; R Amson; A Telerman
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

View more
  2 in total

1.  Differential effects of amyloid-β peptide aggregation status on in vivo retinal neurotoxicity.

Authors:  H R Watts; Pjb Anderson; D Ma; K L Philpott; S M Jen; M Croucher; L S Jen; S M Gentleman
Journal:  Eye Brain       Date:  2010-09-09

2.  Differential effects of interleukin-1beta and S100B on amyloid precursor protein in rat retinal neurons.

Authors:  Peter J B Anderson; Helena R Watts; Sheila Jen; Stephen M Gentleman; Juliet A Moncaster; D T Walsh; Ling-Sun Jen
Journal:  Clin Ophthalmol       Date:  2009-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.